Peculiarities of phenotypic distribution of lymphocytes and their activation markers in patients with infection-based inflammatory
Abstract
Herpes simplex virus has the ability to persist during all the life in the nervous ganglia and cells of the immune system with periodic reactivation and the development of a wide range of clinical manifestations. Clinical manifestations depend on the immune status of the host- from typical vesicular rashes on the red border of the lips, to the development of serious neurological complications, sometimes fatal (usually in immunocompromised people). Immunocompromised patients include patients with congenital immunodeficiencies, HIV infection, iatrogenic immunosuppression after transplantation, as well as patients with systemic connective tissue diseases who receive long-term immunosuppressive therapy. On the other hand, herpesviruses are triggers, under the influence of which there may be a failure of self-tolerance in genetically predisposed individuals. Thus, there is a kind of «vicious circle», when herpes becomes recurrent in people with the existing immunodeficiency, and then the virus itself maintains this condition by persistence and replication in the nerve ganglia and immunocytes. Aim. Assessment of lymphocyte status by lymphocyte phenotyping and determination of activation markers activity in patients with activated HSV 1/2 infection in combination with Connective Tissue Disease (CTD) and compare with groups of patients with CTD only, patients with only activated HSV 1/2 infection and practically healthy individuals. Materials and methods. We monitored 110 patients: 34 individuals with reactive herpes simplex virus infection, 40 individuals with systemic connective tissue disease, and 36 individuals with a combination of reactive herpes simplex virus infection and CTD. Conclusions. Defects in the humoral and cellular parts of the immune system in patients with CTD can provoke inadequate immune protection against pathogenic microorganisms, and lifelong persistence of HSV type 1/2 in immune system cells can lead to death or decreased functional activity of immune system cells and secondary immunodeficiency.
Downloads
References
Hammer MM, Gosangi B, Hatabu H. Human Herpesvirus Alpha Subfamily (Herpes Simplex and Varicella Zoster) Viral Pneumonias: CT Findings. J Thorac Imaging. 2018; 33 (6): 384–389. https://doi.org/10.1097/RTI.0000000000000364
Dilnessa T, Zeleke H. Cell Culture, Cytopathic Effect and Immunofluorescence Diagnosis of Viral Infection. Journal of Microbiology and Modern Techniques. Volume 2. Issue 1: 1–8. http://www.annexpublishers.co/full-text/JMC/2102/Cell-Culture-Cytopathic-Effect-and-Immunofluorescence-Diagnosis-of-Viral-Infection.php
Dyachenko PA, Dyachenko AG. Immune response to HSV infection and causes of persistence of the virus. Clinical immunology. Allergology. Infectology. 2011; № 5: 26–28 . [in Russian]
Karsonova AV, Shulzhenko AE, Karaulov AV. Functional types of response of NK cells to the action of interferon alpha in patients with frequent recurrent herpes simplex. Cytokines and inflammation. 2013; T. 12, № 1/2: 52–56. [in Russian]
Tognarelli EI, Palomino TF, Corrales N. et al. Herpes Simplex Virus Evasion of Early Host Antiviral Responses. Front Cell Infect Microbiol. 2019; 9: 127. https://doi.org/10.3389/fcimb.2019.00127
Suazo PA, Ibañez FJ, Retamal-Díaz AR, Paz-Fiblas M.V. et al. Evasion of Early Antiviral Responses by Herpes Simplex Viruses. Mediators Inflamm. 2015: 593757. https://doi.org/10.1155/2015/593757
Melanie A. Ruffner, Kathleen E. Sullivan, Sarah E. Henrickson Recurrent and Sustained Viral Infections in Primary Immunodeficiencies Frontiers Immunology 2017;Vol. 8:665. https://doi.org/10.3389/fimmu.2017.00665
Chad J. Cooper, Sarmad Said, Mohamed Teleb, Paola Rosa, and S. Claudia Didia An Immunocompetent Patient with a Vesicular Rash and Neurological Symptomatology Hindawi Publishing Corporation. Case report In Medicine Volume 2013. Article ID 168943. https://doi.org/10.1155/2013/168943
Weed DJ, Nicola AV Herpes simplex virus Membrane Fusion. Adv Anat Embryol Cell Biol. 2017; 223: 29–47. https://doi.org/10.1007/978-3-319-53168-7_2
Kennedy Peter GE, Rovnak J, Badani H, Cohrs RJ. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol. 2015; 96 (Pt 7): 1581–1602. https://doi.org/10.1099/vir.0.000128
Vassantachart JM, Mentern A. Recurrent lumbosacral herpes simplex virus infection. Proc (Bayl Univ Med Cent). 2016 Jan; 29 (1): 48–49.
Agelidis AM, Shukla D. Cell entry mechanisms of HSV: what we have learned in recent years. Future Virol. 2015; 10 (10): 1145–1154. https://doi.org/10.2217/fvl.15.85
Jenks JA, Goodwin ML, Permar SR. The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity. Frontiers in Immunology. 2019; Volume 10. Article 2110: 1–9. https://doi.org/10.3389/fimmu.2019.02110
Katzene SL, Leib DA. Herpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory Neurons. Journal of Virology. 2016; Volume 90. Number 9: 4706–4719. https://doi.org/10.1128/JVI.02908-15
Takeuchi O, Akira S. Innate Immunity to Virus Infection. Immunol Rev. 2009; 227 (1): 75–86. https://doi.org/10.1111/j.1600-065X.2008.00737.x
Varlamova TV, Dorshakova NV, Karapetyan TA. Viruses as a cofactors in the process of disorders of autoimmune tolerance. Scientific notes of Petrozavodsk State University. 2016; № 8 (161): 14–19. [in Russian]
Chopyak VV. Lectures on clinical immunology and allergology for general practitioners. 2018. P. 622. [in Ukrainian].
Toussirot Е, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008; 22 (5): 883–96. https://doi.org/10.1016/j.berh.2008.09.007.
Ramos-Casals M, Cuadrado MJ., Alba P, Sanna G. Et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore). 2008 Nov; 87 (6): 311–8. https://doi.org/10.1097/MD.0b013e31818ec711.
Su C, Zhan G., Zheng C. Evasion of host antiviral innate immunity by HSV-1, an update recruitment of the downstream adaptor TBK1. Virol. J. 2016; 13, 38. https://doi.org/10.1186/s12985-016-0495-5
David M. Koelle, Peter Norberg, Matthew P. Fitzgibbon, Ronnie M. Russell et al. Worldwide circulation of HSV-2 × HSV-1 recombinant strains. Sci Rep. 2017; 7: 44084. https://doi.org/10.1038/srep44084
Ibáñez FJ, Farías MA, Gonzalez-Troncoso M P et al. Experimental Dissection of the Lytic Replication Cycles of Herpes Simplex Viruses in vitro. Front Microbiol. 2018; 9: 2406. https://doi.org/10.3389/fmicb.2018.02406
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
